| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2874a198cb5a3593494d36246691632 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
| filingDate |
2002-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b375b658e2d4e9622e77da0ed90961d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa9347c9fe6d1b9a702700f7511e462c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bf0f68df7c2890c2c3760b6aa057b8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ed43d78452548de94f63c09b7e909e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4b63c46b73fc9541a40d8d68e55bf18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ef345e781fda812d17fe8724026f8d1 |
| publicationDate |
2011-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1559426-B1 |
| titleOfInvention |
Percutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one |
| abstract |
Percutaneous absorption preparations (optionally being in the form of patches) which contain as the active ingredient from 0.1 to 30% by mass of 3-methyl-1-pheynyl-2-pyrazolin-5-one represented by the following formula: or its pharmaceutically acceptable salt in an appropriate base, for example, an aqueous base or a rubber base. These preparations (or patches) are excellent percutaneous absorption preparations (or percutaneous absorption patches) showing a high percutaneous absorbability of the active ingredient and little skin irritation. |
| priorityDate |
2002-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |